These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 16222612)
41. Is low-dose hormone replacement therapy for postmenopausal women efficacious and desirable? Lobo RA; Whitehead MI Climacteric; 2001 Jun; 4(2):110-9. PubMed ID: 11428175 [No Abstract] [Full Text] [Related]
42. Reduced incidence of distant metastases and lower mortality in 1072 patients with breast cancer with a history of hormone replacement therapy. Schuetz F; Diel IJ; Pueschel M; von Holst T; Solomayer EF; Lange S; Sinn P; Bastert G; Sohn C Am J Obstet Gynecol; 2007 Apr; 196(4):342.e1-9. PubMed ID: 17403414 [TBL] [Abstract][Full Text] [Related]
43. Hormone replacement therapy post Women's Health Initiative study: where do we stand? Calleja-Agius J; Brincat MP Curr Opin Obstet Gynecol; 2008 Dec; 20(6):513-8. PubMed ID: 18989125 [TBL] [Abstract][Full Text] [Related]
44. [Alternative hormone therapy in postmenopause]. Fistonić I; Canić T; Duić Z; Fistonić M; Ciglar S Lijec Vjesn; 2006; 128(3-4):99-104. PubMed ID: 16808100 [TBL] [Abstract][Full Text] [Related]
45. A prospective, randomized, double-blind, placebo-controlled study on the influence of a hormone replacement therapy on skin aging in postmenopausal women. Sator PG; Sator MO; Schmidt JB; Nahavandi H; Radakovic S; Huber JC; Hönigsmann H Climacteric; 2007 Aug; 10(4):320-34. PubMed ID: 17653959 [TBL] [Abstract][Full Text] [Related]
46. Hyperinsulinaemia, a key factor of the metabolic syndrome in postmenopausal women. Gaspard U Maturitas; 2009 Apr; 62(4):362-5. PubMed ID: 19131194 [TBL] [Abstract][Full Text] [Related]
47. [Hormone replacement Up-to-date. Hormone replacement therapy and brain function]. Mori K; Takeda M Clin Calcium; 2007 Sep; 17(9):1349-54. PubMed ID: 17767023 [TBL] [Abstract][Full Text] [Related]
48. Effects of hormone replacement therapy on insulin resistance and platelet function tests. Saraç F; Saydam G; Sahin F; Oztekin K; Saygili F; Tüzün M; Yilmaz C Med Princ Pract; 2009; 18(1):43-7. PubMed ID: 19060490 [TBL] [Abstract][Full Text] [Related]
49. Does hormonal replacement therapy actually protect against cardiovascular disease? Oleszczuk JJ; Wac M; Kanadys W; Keith LG Int J Fertil Womens Med; 2002; 47(1):38-45. PubMed ID: 11900274 [TBL] [Abstract][Full Text] [Related]
50. Effects of blood pressure reduction on cardiovascular risk estimates in hypertensive postmenopausal women. Preston RA Climacteric; 2007 Feb; 10 Suppl 1():32-41. PubMed ID: 17364596 [TBL] [Abstract][Full Text] [Related]
51. Severe pulmonary hypertension in postmenopausal obese women. Taraseviciute A; Voelkel NF Eur J Med Res; 2006 May; 11(5):198-202. PubMed ID: 16723293 [TBL] [Abstract][Full Text] [Related]
52. [Hypertension in postmenopausal women --selected pathomechanisms]. Pośnik-Urbańska A; Kawecka-Jaszcz K Przegl Lek; 2006; 63(12):1313-7. PubMed ID: 17642147 [TBL] [Abstract][Full Text] [Related]
53. Vasoactive biomarkers and oxidative stress in healthy recently postmenopausal women treated with hormone replacement therapy. Maffei S; Mercuri A; Prontera C; Zucchelli GC; Vassalle C Climacteric; 2006 Dec; 9(6):452-8. PubMed ID: 17085378 [TBL] [Abstract][Full Text] [Related]
54. Prevention of cardiovascular events in early menopause: a possible role for hormone replacement therapy. Antonicelli R; Olivieri F; Morichi V; Urbani E; Mais V Int J Cardiol; 2008 Nov; 130(2):140-6. PubMed ID: 18617278 [TBL] [Abstract][Full Text] [Related]
55. Glycemic targets for patients with type 2 diabetes mellitus. Hamnvik OP; McMahon GT Mt Sinai J Med; 2009 Jun; 76(3):227-33. PubMed ID: 19421966 [TBL] [Abstract][Full Text] [Related]
57. Use, intentions, and beliefs about hormone replacement therapy in women with and without diabetes. Huston SA; Kirking DM; Shimp LA Maturitas; 2006 Aug; 55(1):58-68. PubMed ID: 16504429 [TBL] [Abstract][Full Text] [Related]
58. Implications of recent clinical trials of postmenopausal hormone therapy for management of cardiovascular disease. Rossouw JE Ann N Y Acad Sci; 2006 Nov; 1089():444-53. PubMed ID: 17261787 [TBL] [Abstract][Full Text] [Related]
59. The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results. Kuhl H; Stevenson J Gynecol Endocrinol; 2006 Jun; 22(6):303-17. PubMed ID: 16785155 [TBL] [Abstract][Full Text] [Related]
60. [The role of estradiol metabolites in prevention of cardiovascular diseases by hormone substitution in postmenopause]. Lippert TH; Seeger H; Mueck AO Zentralbl Gynakol; 1999; 121(10):467-72. PubMed ID: 10573819 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]